Allograft nephrectomy: Indications and surgical techniques. Association Française d’Urologie and Société Francophone de Transplantation guidelines
A. Frontczak(Centre Hospitalier Universitaire de Besançon), T. Culty(Centre Hospitalier Universitaire d'Angers), Myriam Pastural(Agence de la Biomédecine), Albane Brodin-Sartorius(Assistance Publique – Hôpitaux de Paris), Thomas Prudhomme(Société Francophone du Diabète), Yanish Soorojebally(Université de Versailles Saint-Quentin-en-Yvelines), Cyril Garrouste(Centre Hospitalier Universitaire de Clermont-Ferrand), Diana Kassab(Lymphoma Study Association), Arnaud Del Bello(Hôpital Rangueil), Emmanuel Morelon(Lyon 1 Université), Emilien Seizilles de Mazancourt(Hôpital Saint-Louis), P. Delpech(Centre Hospitalier Universitaire de Poitiers), A. Goujon(Hôpital Pontchaillou), Brigitte Thevenin-Lemoine(Skin Research Center), Nicolas Congy‐Jolivet(Centre Hospitalier Universitaire de Toulouse), Nicolas Piffault(Renault (France)), F. Kleinclauss(Centre Hospitalier Universitaire de Besançon)
Cited by 1
Related Papers
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
|European Urology|2020|89
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
|British Journal of Urology|2023|64
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review
|World Journal of Urology|2023|42
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
|Urologic Oncology Seminars and Original Investigations|2021|39